SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
Ti
Lv1
1
50 积分
2021-10-14 加入
最近求助
最近应助
互助留言
Neoadjuvant camrelizumab combined with paclitaxel and nedaplatin for locally advanced esophageal squamous cell carcinoma: A single-arm phase 2 study (cohort study)
1个月前
已完结
Continuation or reintroduction of bevacizumab beyond progression to first-line therapy in metastatic colorectal cancer: final results of the randomized BEBYP trial
2个月前
已完结
Neoadjuvant chemotherapy with or without camrelizumab in resectable esophageal squamous cell carcinoma: the randomized phase 3 ESCORT-NEO/NCCES01 trial
2个月前
已完结
First-line cemiplimab monotherapy and continued cemiplimab beyond progression plus chemotherapy for advanced non-small-cell lung cancer with PD-L1 50% or more (EMPOWER-Lung 1): 35-month follow-up from a mutlicentre, open-label, randomised, phase 3 trial
2个月前
已完结
Multikingdom and functional gut microbiota markers for autism spectrum disorder
2个月前
已完结
Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial
3个月前
已完结
Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial
3个月前
已完结
Immunotherapy at all stages of hepatocellular carcinoma
3个月前
已完结
Adjuvant and neoadjuvant immunotherapies in hepatocellular carcinoma
3个月前
已完结
Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
3个月前
已完结
没有进行任何应助
感谢,点赞
2个月前
感谢,点赞
2个月前
感谢,帮大忙了
2个月前
感谢,点赞
2个月前
感谢,点赞
3个月前
感谢,点赞
3个月前
感谢,点赞
3个月前
感谢,点赞
3个月前
感谢,点赞
3个月前
感谢
4个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论